| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |